BG prices offering

Shares of BG Medicine (BGMD -18.7%) are down in early trading in response to its public offering of 6,452,000 common shares at $1.55/share. Net proceeds will be $8.9M.

Underwriters over-allotment is 967,800 shares.

Proceeds will be used to advance the commercialization of its cardiovascular diagnostic tests, CAPEX, IP licensing, debt repayment and working capital.

Closing date is April 8.

Comments (1)
  • Genoregrets
    , contributor
    Comments (45) | Send Message
    Thanks $BGMD glad your making money pricing shares at 45 cents less than the previous days close . Great business plan
    3 Apr 2014, 09:50 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs